TORONTO — Beena Goldenberg will retire as CEO of Organigram Global Inc. at the conclusion of the Company’s current fiscal year ending September 30, 2025. Until this date, Goldenberg will continue as CEO and a member of the Company’s Board of Directors to advance Organigram’s strategic objectives, including international expansion, and to ensure an effective transition.
Since joining Organigram as CEO in September 2021, Goldenberg led the organization’s growth and transformation from a cannabis company with $80M in net revenue to becoming the market share leader in Canada with over $250M in net revenue. Under her leadership, the Company completed an expansion of its facility in Moncton, New Brunswick, doubling cultivation capacity, as well as three strategic acquisitions in vapes, hash, and pre-rolls in Canada. In addition, Goldenberg oversaw Organigram’s international expansion with export sales into Germany, UK, and Australia. The latest acquisition of Collective Project, announced April 1, signaled the first revenue recognized by Organigram from the U.S. market.
This announcement follows the Company’s second quarter fiscal year 2025 results, which were issued on May 12, 2025, and highlight the progress that has been made in enhancing Organigram’s financial performance. This includes realizing a 74% increase in net revenue year-over-year and delivering improvement across key financial metrics.
“After five incredible years in the cannabis industry, serving as CEO of Supreme Cannabis Company and Organigram Global, I have decided it is time to move on to my next chapter,” said Goldenberg. “Reflecting on my journey, I am extremely proud of what has been accomplished in this nascent industry. The challenges we faced and the successes we achieved underscore the immense potential that still lies ahead for the cannabis industry.”
“On behalf of the Board, I express our gratitude to Beena for her exceptional leadership and commitment to Organigram. Beena has been instrumental in positioning Organigram as a market leader in Canada and poised for global expansion,” said Peter Amirault, Chairman of the Board. “She has created an excellent base for both domestic and international growth for Organigram. And therefore, the Company is well positioned to take advantage of this significant opportunity. The Board remains confident in the Company’s strategic direction as well as its leadership team, and we are committed to appointing a new CEO who will continue to drive our vision forward, ensuring that the Company remains at the forefront of cannabis innovation and growth.”
The Board is in the process of initiating a comprehensive CEO selection process focused on identifying a candidate with the right mix of skills and experience to lead the Company in its next chapter of growth.
“It has been an honour to lead Organigram Global through this critical chapter in our evolution, and I am grateful to have had the privilege of working with so many talented and passionate people who have played a significant role in our collective growth and achievements,” said Goldenberg. “Over the next four months I will remain focused on driving Organigram growth and profitability while supporting the smooth onboarding of a new CEO to lead the Company forward in its next phase of growth.”
About Organigram
Organigram Global Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly owned subsidiaries include Organigram Inc., a licensed cultivator and processor of cannabis and manufacturer of cannabis-derived goods in Canada. Through its recent acquisition of Collective Project Limited, Organigram Global participates in the US and Canadian cannabinoid beverages markets.
Related Articles:
